Spotlight Innovation Obtains Exclusive, Worldwide License from Florida State University Research Foundation to Commercialize Therapeutics for Zika Virus Infection

WEST DES MOINES, Iowa, Dec. 13, 2016 /PRNewswire/ Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company advancing technologies designed to address rare, emerging and neglected diseases, today announced that the Company has obtained from the Florida State University Research Foundation exclusive, worldwide rights to develop and commercialize certain compounds for the treatment of viral infections, including Zika virus infection. Included among the licensed compounds are those identified in a study1 co-authored by Florida State University Professor Hengli Tang that
http://bit.ly/2gyjZ5l